Safer Parenteral Nutrition in Pediatric Short Bowel Syndrome to Decrease Liver Damage
Status:
Approved for marketing
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To provide children dependent on total parenteral nutrition with Omegaven®, a fish oil-based
intravenous lipid emulsion that may be less hepatotoxic than conventional, vegetable
oil-based intravenous lipid emulsions, and that may therefore reduce the need for liver
transplantation.